By leveraging the world's largest clinical trial dataset, we streamline clinical trial design — and match you with the right partner from our 20,000+ global life science service provider network.
MEDIAIPLUS turns the world's largest clinical trial dataset into clear decisions. We streamline trial design and connect you with the right partner from a 20,000+ global life science service provider network — breaking bottlenecks to drive a virtuous cycle in clinical trials.
Scattered intelligence, brought into one place — so your experts spend their time on judgement, not legwork.
Every recommendation is grounded in 730,000+ clinical trial records and 1.2M+ FDA records — the world's largest clinical trial dataset.
A curated network of 20,000+ CROs, CDMOs, SMOs, and Tech/AI vendors, matched to your trial objectives in days — not weeks.
Curation and drafting that cut labor-intensive prep time, without cutting rigor or traceability.
Operators and partners across pharma, biotech, and government on what changed after working with us.
I'm happy to pay for more CRO information. Until now I've relied on my personal network, but it had its limitations. MEDIAIPLUS offers a much broader and more reliable resource.
MEDIAIPLUS's team and service is revolutionary. Many clients have lost money searching for a CRO only to find it's not a good fit. MEDIAIPLUS's network of global CROs will help you complete your goals anywhere in the world.
MEDIAIPLUS's network of over 29,000 CROs is extensive. Collaboration with the Belgian biotech industry is already underway, and we look forward to seeing even more global partnerships in the future.
FiCRO connects you with the right partner from a curated network of 20,000+ life science service providers — CROs, CDMOs, SMOs, and Tech/AI vendors — matched to your trial objectives.
Our network spans every therapeutic area and region. Submit your trial parameters once and FiCRO narrows the field for you, with verified capability records and direct introductions from our team.
Access all protocol design essentials in one place: drugs, diseases, modalities, guidelines, similar trials, and competing drugs.
— Life Sciences Professional, CSO Tarik S. Chaudhry
Bring drugs, diseases, modalities, guidelines, and similar trials into one workspace, and let AI surface what matters for your next protocol.
MedidraftAI analyzes 730,000+ clinical trial records to recommend a regulatory path, benchmark similar devices, and auto-generate an evidence-based protocol draft — complete with source citations.
Built on a RAG architecture over 730,000+ clinical trials and 1.2M+ FDA records, MedidraftAI handles the labor-intensive groundwork — so your experts can focus on the judgement calls that actually move the trial forward.
Clinical evidence is scattered across trial registries, literature, patents, and guidelines. MediScholar unifies them into a single knowledge graph and drafts a purpose-aligned report — where every claim, number, and conclusion traces back to its source.
MediScholar's KG-RAG engine interprets your intent, searches the connected sources, and cross-checks every statement against the original before assembling a structured draft. Passages that need human judgment — off-label use, dosing, regulatory interpretation — are flagged for expert review rather than stated as fact.
Clinical trials are complicated and challenging. Delays in development can result in significant financial loss. MEDIAIPLUS turns scattered intelligence into a single decision surface.
Tell us about your pipeline and the trials you're planning. We'll come back to you within a working day.
Contact Us